Stay Ahead Marcel Alavi 5/12/26 Marcel Alavi 5/12/26 712 North Inc. Announces Publication of Authoritative Review on OPA1 Pathway and Therapeutic Strategies in Autosomal Dominant Optic Atrophy Read More Marcel Alavi 11/11/25 Marcel Alavi 11/11/25 712 North Inc. Expands Intellectual Property Portfolio with New USPTO Patent for OMA1/OPA1 Modulators Read More Marcel Alavi 5/28/24 Marcel Alavi 5/28/24 712 North Inc. Announces USPTO Grant of New Patent for Innovative OMA1 Protease Modulators Read More Marcel Alavi 1/13/22 Marcel Alavi 1/13/22 712 North Inc. Highlights Novel OMA1 Screening Approaches in New Publication Read More Marcel Alavi 10/21/21 Marcel Alavi 10/21/21 712 North Inc. Announces Landmark Publication of OMA1 High-Throughput Screening Platform Read More Marcel Alavi 8/13/21 Marcel Alavi 8/13/21 712 North Inc. Unveils New Research Clarifying the Relationship Between Tau and the Mitochondrial OPA1/OMA1 Pathway in Alzheimer’s Disease Read More Marcel Alavi 2/2/21 Marcel Alavi 2/2/21 712 North Inc. Expands IP Portfolio with USPTO Patent for Treating Mitochondrial Diseases Read More Marcel Alavi 10/29/20 Marcel Alavi 10/29/20 712 North Inc. Proposes New Structural Paradigm for OMA1 Protease in BBA – Proteins and Proteomics Publication Read More Marcel Alavi 7/1/19 Marcel Alavi 7/1/19 712 North Inc. Establishes New Laboratory at the QB3 Garage at UC Berkeley Read More Marcel Alavi 3/30/19 Marcel Alavi 3/30/19 712 North Inc. Awarded NIH SBIR Grant to Advance Discovery of Novel OMA1 Inhibitors Read More Marcel Alavi 2/4/19 Marcel Alavi 2/4/19 712 North Inc. Identifies OMA1 as a Potential New Oncology Target in International Journal of Cancer Publication Read More
Marcel Alavi 5/12/26 Marcel Alavi 5/12/26 712 North Inc. Announces Publication of Authoritative Review on OPA1 Pathway and Therapeutic Strategies in Autosomal Dominant Optic Atrophy Read More
Marcel Alavi 11/11/25 Marcel Alavi 11/11/25 712 North Inc. Expands Intellectual Property Portfolio with New USPTO Patent for OMA1/OPA1 Modulators Read More
Marcel Alavi 5/28/24 Marcel Alavi 5/28/24 712 North Inc. Announces USPTO Grant of New Patent for Innovative OMA1 Protease Modulators Read More
Marcel Alavi 1/13/22 Marcel Alavi 1/13/22 712 North Inc. Highlights Novel OMA1 Screening Approaches in New Publication Read More
Marcel Alavi 10/21/21 Marcel Alavi 10/21/21 712 North Inc. Announces Landmark Publication of OMA1 High-Throughput Screening Platform Read More
Marcel Alavi 8/13/21 Marcel Alavi 8/13/21 712 North Inc. Unveils New Research Clarifying the Relationship Between Tau and the Mitochondrial OPA1/OMA1 Pathway in Alzheimer’s Disease Read More
Marcel Alavi 2/2/21 Marcel Alavi 2/2/21 712 North Inc. Expands IP Portfolio with USPTO Patent for Treating Mitochondrial Diseases Read More
Marcel Alavi 10/29/20 Marcel Alavi 10/29/20 712 North Inc. Proposes New Structural Paradigm for OMA1 Protease in BBA – Proteins and Proteomics Publication Read More
Marcel Alavi 7/1/19 Marcel Alavi 7/1/19 712 North Inc. Establishes New Laboratory at the QB3 Garage at UC Berkeley Read More
Marcel Alavi 3/30/19 Marcel Alavi 3/30/19 712 North Inc. Awarded NIH SBIR Grant to Advance Discovery of Novel OMA1 Inhibitors Read More
Marcel Alavi 2/4/19 Marcel Alavi 2/4/19 712 North Inc. Identifies OMA1 as a Potential New Oncology Target in International Journal of Cancer Publication Read More
